Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 22

Trial Status

Terminated3

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT00465842Terminated
Protein Biomarker in Hepatocellular Carcinoma
HepatitisHepatocellular CarcinomaLiver Cirrhosis+1 more
PrincipalinvestigatorStart date: 2006-06-20
NCT00484601Phase 2Terminated
Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma
Refractory Nasopharyngeal Carcinoma
PrincipalinvestigatorStart date: 2004-04-15

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT00465842PrincipalInvestigator

Protein Biomarker in Hepatocellular Carcinoma

HepatitisHepatocellular CarcinomaLiver Cirrhosis+1 more
Terminated
NCT00484601Phase 2PrincipalInvestigator

Ifosfamide and Doxorubicin in Patients With Refractory Nasopharyngeal Carcinoma

Refractory Nasopharyngeal Carcinoma
Terminated
NCT00465907Phase 2PrincipalInvestigator

Study of Weekly Paclitaxel, Carboplatin and Irinotecan to Treat Lung Cancer

Lung Cancer
Terminated

All 3 trials loaded